SADHANA NITROCHEM LTD.

Sadhana Nitro Chem Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as required by SEBI regulations. The report, which is part of the company's Annual Report, details its operations, products, employee data, and market reach. Key disclosures include business activities accounting for 90% of turnover, with manufacturing of chemicals and chemical products contributing 95%. The company serves domestic and international markets, with exports forming 15% of its turnover. The report also provides employee statistics, including permanent and other than permanent staff, and details on differently-abled employees.

Sadhana Nitro Chem Limited announced its 53rd Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 02:00 PM IST via Video Conferencing (VC)/Other Audio-Visual Means (OAVM). The meeting will transact business including the adoption of the Audited Financial Statements for FY 2025-26, re-appointment of Mrs. Seema A. Javeri as director, ratification of cost auditors' remuneration, and re-appointment of Mr. Asit D. Javeri as Executive Chairman. E-voting facilities will be available from September 27 to September 29, 2026. The AGM notice and annual report are available on the company's website.

Sadhana Nitro Chem Limited has announced its 53rd Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 02:00 P.M. IST via Video Conferencing (VC)/ Other Audio-Visual Means (OAVM). This format is permitted by the Ministry of Corporate Affairs (MCA) and SEBI, allowing for remote e-voting. The cut-off date for e-voting eligibility is September 23, 2026, with the e-voting period commencing on September 27, 2026, and concluding on September 29, 2026. The Annual Report for FY 2025-26 and the Notice of AGM are available on the company's website.

Niraj Bajaj has disclosed a substantial acquisition of shares in Sadhana Nitrochem Ltd. through a preferential allotment. The acquisition involves 5,25,00,000 equity shares, increasing the acquirer's total holding to 20,00,00,000 equity shares. This transaction significantly alters the shareholding structure of Sadhana Nitrochem, with the total equity capital increasing from 206,46,94,385 shares to 303,21,94,385 shares post-acquisition. The filing is made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Niraj Bajaj has disclosed a substantial acquisition of shares in Sadhana Nitrochem Ltd. through a preferential allotment. Prior to this acquisition, Bajaj held 14,75,00,000 shares. The recent transaction involved acquiring an additional 5,25,00,000 equity shares. Following this acquisition, Niraj Bajaj's total holding in Sadhana Nitrochem Ltd. stands at 20,00,00,000 shares. The total equity share capital of the company increased from 296,46,94,385 shares to 303,21,94,385 shares post-acquisition. This disclosure is made under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Sadhana Nitro Chem Ltd has submitted its second Monitoring Agency Report for the quarter ended June 30, 2026, concerning the utilization of proceeds from its Rights Issue. The report, issued by Acuite Ratings and Research Limited, confirms that there has been no deviation or variation in the utilization of funds as per the disclosures in the Offer Document. The company's Audit Committee has reviewed the report. The Rights Issue, which closed on March 10, 2026, had an issue size of ₹263.53 Crores. The company also confirmed that utilization is in line with the objects of the issue and no shareholder approval was required due to the absence of material deviations.

Sadhana Nitro Chem Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors also approved a preferential issue, allotting 6,75,00,000 equity shares at Rs. 2.06 per share. This allotment increases the company's paid-up equity share capital from Rs. 296,46,94,385 to Rs. 303,21,94,385. The results were reviewed by statutory auditors, Jayesh Dadia & Associates LLP.

Sadhana Nitro Chem's consolidated Q1 FY27 (quarter ended June 30, 2026) net loss narrowed to ₹0.55 Cr from ₹2.12 Cr a year earlier, even as revenue from operations slipped 3.1% YoY to ₹27.22 Cr from ₹28.10 Cr. The improvement is margin-led rather than volume-led: operating margin (EBITDA/revenue) expanded to ~8.5% from ~6.9% in Q1 FY26, and net margin (PAT/total income) improved to -1.8% from -6.5%, aided by lower finance costs (₹3.19 Cr vs ₹4.01 Cr YoY). Standalone (parent-only) results were similar — a ₹0.40 Cr loss on ₹26.18 Cr revenue — with the gap to consolidated explained by Belgian subsidiary Anuchem B.V.B.A., which added ₹5.62 Cr of revenue and a ₹0.12 Cr pre-tax loss to the group. Sequentially both revenue and profit look sharply better than the March 2026 quarter (₹9.11 Cr revenue, ₹33.62 Cr loss), but auditors flag Q4 FY26 as a balancing/plug figure, so that comparison is not a clean momentum read. The company carries no formal guidance or prior concall commentary on record, and no analyst/street estimates could be identified for this print, so both the guidance and street checks are unknown rather than a stated beat or miss. Management's release carries no commentary beyond the results and board outcomes. Two corporate actions landed alongside the results: the board approved a ₹13.9 Cr preferential allotment of 6.75 Cr shares at ₹2.06 apiece the same day, taking paid-up capital from ₹296.47 Cr to ₹303.22 Cr, and separately confirmed no deviation in utilization of rights-issue proceeds — both balance-sheet items, not P&L drivers this quarter. The ₹108 Cr speciality-chemical export deal announced May 28, 2026 has not yet shown up as revenue growth here (revenue is still down YoY), suggesting execution is still ahead of this print rather than in it. EPS is effectively nil (~₹0.00) on both bases given the roughly 296 Cr-share base, and neither period carried exceptional items.

Sadhana Nitro Chem Ltd has announced that its Board of Directors will convene on August 7, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the limited review report. Additionally, the meeting will address any other business arising from discussions. The company also confirmed that the trading window for designated persons remains closed until 48 hours after the declaration of these financial results, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Sadhana Nitro Chem Ltd has received in-principle approval from both BSE and NSE for a proposed preferential issue of 6,75,00,000 equity shares of Re. 1/- each at a price not less than Rs. 2.06/- per share to non-promoters. The approval is conditional upon compliance with various SEBI regulations, including the ICDR and LODR Regulations. The company must obtain undertakings from allottees regarding trading restrictions and strengthen internal controls. Failure to comply may impact the listing of the shares. The company is required to make a listing application within twenty days of allotment.